The State of Oncology in 2026 With ZS
Immunõ 2026: Global Virtual Congress on Immuno Oncology
Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications
Pfizer to Present 45 Abstracts at ESMO 2026, With Data in Breast, Genitourinary, Lung Cancers and Melanoma
A New Era in Cervical Cancer Prevention in Algeria: Integration of HPV Vaccination into the National Immunization Program
Radiotherapy for R/R Hodgkin Lymphoma: Targeting Residual Disease After BV and PD-1 Blockade
Deulorlatinib in ALK-Positive NSCLC: Can Deuteration Improve on Lorlatinib?
EVOLUTE: Enfortumab Vedotin in Older Patients With Advanced Urothelial Carcinoma
